IDO2 and neoplasm: In another study conducted on mice, the combined use of a stimulator of interferon gene (STING) agonist and an indoleamine 2,3-dioxygenase (IDO) inhibitor led to the recruitment of CD8+ T cells and dendritic cells, which in turn inhibited tumor cell growth [136].